Free Trial

Roundhill GLP-1 & Weight Loss ETF Rating

Roundhill GLP-1 & Weight Loss ETF logo
$26.89 +0.04 (+0.15%)
As of 07/25/2025 03:42 PM Eastern

Roundhill GLP-1 & Weight Loss ETF Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

OZEM Aggregate Rating

Moderate Buy
2.66

Holdings in OZEM have an aggregate rating of Moderate Buy based on 194 analyst ratings issued in the past year covering 14 companies (71.2% of the portfolio).

OZEM Aggregate Price Target

$26.89
High Prediction$26.89
Average Prediction$26.89
Low Prediction$26.89

Holdings in OZEM have an aggregate price target of $26.89 and a range of $26.89 to $26.89 covering 14 companies (71.2% of the portfolio).

OZEM Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
Moderate Buy
6 Moderate Buy rating(s)
Hold
3 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Roundhill GLP-1 & Weight Loss ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 14 OZEM Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
17.11%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$71.67
+1.3%
4.1567 of 5 stars
2.27$112.00 56.3%11Positive News
15.71%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$811.73
+0.8%
4.8999 of 5 stars
2.75$1,012.56 24.7%20Trending News
Analyst Upgrade
5.00%
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
$34.42
+2.7%
4.8431 of 5 stars
3.00$86.92 152.5%14Trending News
Earnings Report
Analyst Forecast
Analyst Revision
4.66%
Metsera Inc. stock logo
MTSR
Metsera
$40.47
+2.1%
N/A3.00$55.00 35.9%5Lockup Expiration
Gap Up
4.12%
Pfizer Inc. stock logo
PFE
Pfizer
$24.79
-2.2%
4.981 of 5 stars
2.45$28.55 15.2%22Trending News
Options Volume
3.98%
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
$6.05
-0.2%
3.977 of 5 stars
2.60$15.63 158.3%5Positive News
3.39%
Amgen Inc. stock logo
AMGN
Amgen
$306.58
-0.6%
4.4009 of 5 stars
2.35$307.27 0.2%23Positive News
Analyst Forecast
3.35%
AstraZeneca PLC stock logo
AZN
AstraZeneca
$72.66
-1.4%
2.9284 of 5 stars
2.83$89.00 22.5%6Upcoming Earnings
3.27%
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
$17.94
-1.8%
2.9141 of 5 stars
3.00$76.17 324.6%7Positive News
2.58%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$563.10
-0.3%
4.8271 of 5 stars
2.75$828.86 47.2%24Trending News
Upcoming Earnings
Analyst Forecast
2.42%
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
$38.95
-0.4%
3.2934 of 5 stars
3.13$42.67 9.5%8Positive News
2.15%
Altimmune, Inc. stock logo
ALT
Altimmune
$4.08
-0.7%
1.9551 of 5 stars
2.75$18.20 346.1%8
1.90%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$116.20
+2.7%
4.9037 of 5 stars
2.81$112.36 -3.3%26Trending News
Analyst Upgrade
1.53%
Biohaven Ltd. stock logo
BHVN
Biohaven
$13.50
-1.4%
2.3202 of 5 stars
3.07$58.46 333.2%15Trending News

This page (NASDAQ:OZEM) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners